tiprankstipranks

John P. Kenny Insider Profile

4 Followers
John P. Kenny, CEO, Director, Ten Percent Owner at Meridian Bioscience, holds 114.28K shares in Quantum-Si (Ticker: QSI), holds 0.00 shares in Meridian Bioscience (Ticker: VIVO), holds 0.00 shares in Biomerica (Ticker: BMRA).
tipranks
John P. Kenny

John P. Kenny
Meridian Bioscience (VIVO)
CEO, Director, Ten Percent Owner

Ranked #2,175 out of 99,024 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+151.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$185K
100.00%
0.00%
A breakdown of John P. Kenny's holdings

Insider Roles

Quantum-Si
(QSI)
Director
Biomerica
(BMRA)
Director
Roles that John P. Kenny holds in companies

Most Profitable Insider Trade

Stock:
Meridian Bioscience
(VIVO)
Rating:Informative Buy
Date:Mar 13, 2020 - Mar 13, 2021
Return:+275.30%
The most profitable trade made by John P. Kenny

John P. Kenny's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
VIVO
Meridian Bioscience
Jan 31, 2023
Uninformative Sell
$0.00
Quantum-Si
May 24, 2023
Director
Uninformative Buy
$185.14K
Biomerica
Director
$0.00
List of latest transactions for each holding click on a transaction to see John P. Kenny's performance on stock

John P. Kenny insider profile FAQ

What is the percentage of profitable transactions made by John P. Kenny?
The percentage of profitable transactions made by John P. Kenny is 100%.
    What is the average return per transaction made by John P. Kenny?
    The average return per transaction made by John P. Kenny is 151.50%.
      What stocks does John P. Kenny hold?
      John P. Kenny holds: VIVO, QSI, BMRA stocks.
        What was John P. Kenny’s latest transaction?
        John P. Kenny latest transaction was an Uninformative Buy of ―.
          What was John P. Kenny's most profitable transaction?
          John P. Kenny’s most profitable transaction was an Informative Buy of VIVO stock on March 13, 2020. The return on the trade was 275.30%.
            What is John P. Kenny's role in Meridian Bioscience?
            John P. Kenny's role in Meridian Bioscience is CEO, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.